Pmu1a, a novel spider toxin with dual inhibitory activity at pain targets hNa <sub>V</sub> 1.7 and hCa <sub>V</sub> 3 voltage‐gated channels
Julien Giribaldi(École Nationale Supérieure de Chimie de Montpellier), Sébastien Dutertre(École Nationale Supérieure de Chimie de Montpellier), Christina I. Schroeder(Research Institute for Bioscience and Biotechnology), Emmanuel Bourinet(Centre National de la Recherche Scientifique), Jean Chemin(Centre National de la Recherche Scientifique), Marie Tuifua(École Nationale Supérieure de Chimie de Montpellier), Jennifer R. Deuis(The University of Queensland), Norelle L. Daly(Australian Institute of Tropical Health and Medicine), Irina Vetter(Centre National de la Recherche Scientifique), David T. Wilson(Australian Institute of Tropical Health and Medicine), Rosanna Mary(École Nationale Supérieure de Chimie de Montpellier)
Cited by 6
Related Papers
A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
|Nature Medicine|2015|2.8k
Methods Used to Evaluate Pain Behaviors in Rodents
|Frontiers in Molecular Neuroscience|2017|1.3k
Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy
|Frontiers in Molecular Neuroscience|2017|654
Silencing of the Cav3.2 T‐type calcium channel gene in sensory neurons demonstrates its major role in nociception
|The EMBO Journal|2004|438
Conus Venom Peptide Pharmacology
|Pharmacological Reviews|2012|422